Inventor
KHAN TANWEER A
US14 patents
⚠️ This page may combine multiple inventors who share the name “KHAN TANWEER A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ATAI THERAPEUTICS INC
4 patentsUS12065405B2Aug 20, 2024
Prodrugs and conjugates of dimethyltryptamine
ATAI THERAPEUTICS INC4 citations73
US12012381B2Jun 18, 2024
Dimethyltryptamine analogues as nitric oxide delivery drugs
ATAI THERAPEUTICS INC4 citations73
US12344570B2Jul 1, 2025
Aminotetraline activators of serotonin receptors
ATAI THERAPEUTICS INC0 citations61
US12351537B2Jul 8, 2025
Dimethoxyphenylalkylamine activators of serotonin receptors
ATAI THERAPEUTICS INC0 citations57
ATAI Life Sciences AG
3 patentsUS11643391B2May 9, 2023
Prodrugs and conjugates of dimethyltryptamine
ATAI Life Sciences AG7 citations83
US11912680B2Feb 27, 2024
Nitric oxide releasing prodrugs of MDA and MDMA
ATAI Life Sciences AG3 citations72
US11827580B2Nov 28, 2023
Aminotetraline activators of serotonin receptors
ATAI Life Sciences AG4 citations72
MERCK SHARP & DOHME
3 patentsUS9428476B2Aug 30, 2016
S-imino-S-oxo-iminothiadiazine compounds as BACE inhibitors, compositions, and their use
MERCK SHARP & DOHME2 citations51
US9422255B2Aug 23, 2016
S-imino-S-oxo-iminothiazine compounds as BACE inhibitors, compositions, and their use
MERCK SHARP & DOHME2 citations51
US9156848B2Oct 13, 2015
Treating diabetes with dipeptidyl peptidase-IV inhibitors
MERCK SHARP & DOHME0 citations41